Actavis plc, which is technically an Irish company following the transfer of its headquarters to Dublin in 2013 for tax purposes, is in advanced talks to acquire rival drug maker Forest Laboratories Inc in a deal that could value Forest at up to $25bn, according to The Wall Street Journal.
The Journal says the deal is expected to be announced as early as Tuesday, its
contacts said. However, it also said that it's possible the talks could still
Actavis is known for its generic drugs, but last year it bought Warner Chilcott, an Irish provider of branded treatments for gastrointestinal and urological conditions.
Actavis plc is listed on the New Stock Exchange, and it says while its global headquarters is located in Dublin, Ireland, its administrative headquarters is based in Parsippany, New Jersey, USA.
Check out our subscription service, Finfacts Premium , at a low annual charge of €25
© Copyright 2011 by Finfacts.com